- No ratings yet
- 187
- 346
- 0
- Jun 22
- A Wall Street Genius’s Final Investment Playbook Novel
Synopsis
Si-heon, a physician turned hedge fund mogul, spent his first life accumulating wealth through biotech investments only to perish from an incurable autoimmune disorder. After regressing a decade, he returns to the start of his career with his memories intact. Now, he aims to secure the financial resources necessary to fund the research for his own survival. This reads like a classic regression power fantasy blended with the high-stakes corporate drama of titles like Billions. It is ideal for fans of technical expert protagonists and the second chance subgenre. Those seeking a lighthearted story or those who dislike dense financial and medical jargon should skip it. The narrative maintains a steady, calculated pace, standing out for its unique synthesis of medical knowledge and aggressive market speculation.
📚 Chapters (346 total)
More Seinen Novels
Browse more
Ratings & Reviews
Rate this novel
Tap a star to rate
Editorial Review
With 346 chapters already published, this work demonstrates a commitment to long-form storytelling and a detailed plot. The primary strength lies in its specific focus on biotech investments, which elevates the story above standard financial fantasies by adding a layer of medical authenticity. However, the protagonist's pathological relationship with money may make him difficult to root for in the early stages. Given the ongoing status and the sheer volume of content, the novel offers significant value for those who enjoy methodical progression. Despite the strong premise, the lack of broader visibility suggests it may be a hidden gem or struggling to find its niche. It is a solid entry in the Seinen category that balances professional ambition with a desperate fight for survival.